# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced b...
JP Morgan analyst Lisa Gill maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $19 to $16.
B of A Securities analyst Allen Lutz maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $1...
Wells Fargo analyst Stephen Baxter maintains Teladoc Health (NYSE:TDOC) with a Equal-Weight and lowers the price target from...
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...
Oppenheimer analyst Michael Wiederhorn maintains Teladoc Health (NYSE:TDOC) with a Outperform and lowers the price target fr...
TD Cowen analyst Charles Rhyee maintains Teladoc Health (NYSE:TDOC) with a Hold and lowers the price target from $16 to $15.